Efficacy and Safety of Nilotinib in Patients With a Chronic Disease of the Graft Against the Host

Update Il y a 4 ans
Reference: NCT02891395

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

Open label non-randomized multicenter phase 2 trial with direct individual benefice


Inclusion criteria

  • Graft-versus-host disease

Links